Neimeth International Pharmaceuticals, on Monday, hinted to investors through the Nigerian Stock Exchange that its board at a meeting on Friday, January 15, 2021, approved the raising of N5bn fresh equity capital.

While details are still sketchy, a notice filed by Florence Onyenekwe, its company secretary, said the board resolution will be presented for approval at the annual general meeting of the company holding on March 9, 2021.